Korro Bio Inc.

NASDAQ: KRRO · Real-Time Price · USD
20.27
0.39 (1.96%)
At close: Aug 15, 2025, 3:59 PM
20.66
1.90%
After-hours: Aug 15, 2025, 07:58 PM EDT

Korro Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
55.64M 166.15M 36.33M 83.49M
Short-Term Investments
70.45M n/a 18.91M 35.04M
Long-Term Investments
36.96M 3.41M n/a n/a
Other Long-Term Assets
6.2M 2.71M 4.77M 659K
Receivables
1.7M n/a 449K 144K
Inventory
n/a n/a n/a -144K
Other Current Assets
3.74M 3.56M 154K 600K
Total Current Assets
131.53M 172.73M 57.08M 119.78M
Property-Plant & Equipment
51.55M 42.81M 11.89M 7.14M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
94.71M 48.94M 16.66M 7.8M
Total Assets
226.24M 221.66M 73.74M 127.58M
Account Payables
3.99M 7.28M 2.6M 789K
Deferred Revenue
3.51M n/a 2.97M -2.58M
Short-Term Debt
1.28M 1.99M 2.92M 2.58M
Other Current Liabilities
2.77M -1.6M -3.06M -215K
Total Current Liabilities
14.96M 19.48M 8.7M 4.95M
Long-Term Debt
n/a n/a 163.86M 14.17M
Other Long-Term Liabilities
1.47M 1.05M n/a 150.67M
Total Long-Term Liabilities
50.87M 32.27M 164.07M 164.83M
Total Liabilities
65.83M 51.75M 172.77M 169.78M
Total Debt
44.77M 33.21M 3.13M 45.6M
Common Stock
9K 8K 35K 5K
Retained Earnings
-266.59M -183M -101.83M -43.8M
Comprehensive Income
268K n/a -5K -7K
Shareholders Equity
160.41M 169.91M -99.03M -42.21M
Total Investments
107.41M 3.41M 18.91M 35.04M